Home
/
People
/
Javier Gasse

Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial - Wellbeing...

Javier Gasse
Wed, Nov 30
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial $KONEF $NMLSF https://t.co/PYwPQpj9Rs via @Benzinga
0
Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc.
Read More
Discover
Javier Gasse
News
Addiction
Cannabis
Dispensary
Health
Opioids
Psychedelics
Science